Catherine Wood's LAB Position Overview
Catherine Wood (via Ark Investment Management LLC) currently holds 3.07 M shares of Standard BioTools Inc. (LAB) worth $3.93 M, representing 0.03% of the portfolio. First purchased in 2024-Q1, this short-term holding has been held for 8 quarters.
Based on 13F filings, Catherine Wood has maintained this position in LAB for several quarters, showing initial confidence in the investment. Largest addition occurred in Q1 2025, adding 129,201 shares. Largest reduction occurred in Q4 2024, reducing 5.63 M shares.
Analysis based on 13F filings available since 2013 Q2
Catherine Wood's Standard BioTools (LAB) Holding Value Over Time
Track share changes against reported price movement
Quarterly Standard BioTools (LAB) Trades by Catherine Wood
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2024 | +13.04 M | New Buy | 13.04 M | $2.71 |
| Q2 2024 | -363,049 | Reduce 2.78% | 12.68 M | $1.77 |
| Q3 2024 | -3.73 M | Reduce 29.41% | 8.95 M | $1.93 |
| Q4 2024 | -5.63 M | Reduce 62.86% | 3.32 M | $1.75 |
| Q1 2025 | +129,201 | Add 3.89% | 3.45 M | $1.08 |
| Q2 2025 | -297,835 | Reduce 8.63% | 3.16 M | $1.20 |
| Q3 2025 | -133,327 | Reduce 4.23% | 3.02 M | $1.30 |
| Q4 2025 | +44,937 | Add 1.49% | 3.07 M | $1.28 |
Catherine Wood's Standard BioTools Investment FAQs
Catherine Wood first purchased Standard BioTools Inc. (LAB) in Q1 2024, acquiring 13,042,440 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Catherine Wood has held Standard BioTools Inc. (LAB) for 8 quarters since Q1 2024.
Catherine Wood's largest addition to Standard BioTools Inc. (LAB) was in Q1 2024, adding 13,042,440 shares worth $35.35 M.
According to the latest 13F filing for Q4 2025, Catherine Wood's firm, Ark Investment Management LLC, owns 3,066,665 shares of Standard BioTools Inc. (LAB), valued at approximately $3.93 M.
As of the Q4 2025 filing, Standard BioTools Inc. (LAB) represents approximately 0.03% of Catherine Wood's publicly disclosed stock portfolio, making it one of their key holdings.
Catherine Wood's peak holding in Standard BioTools Inc. (LAB) was 13,042,440 shares, as reported at the end of Q1 2024.